Showing posts with label Shasun Pharma. Show all posts
Showing posts with label Shasun Pharma. Show all posts

Tuesday, April 12, 2016

Shasun Pharma

Delisting of Companies
 
Content
Sub: Delisting of Companies


Trading Members of the Exchange are hereby informed that the under mentioned scrip codes of the companies which
 have been suspended due to Amalgamation, scheme of arrangement  etc., will be delisted with effect from April 20, 2016
(DR-013/2016-2017):
                                                                                                                                             

Sr.
No.
Scrip Code No.
Name of the Company
ISIN No.
Reasons
1
524552
Shasun Pharmaceuticals Ltd.

INE317A01028
Amalgamation of Shasun Pharmaceuticals Ltd. into Strides Arcolab  Ltd
2
624552
Shasun Pharmaceuticals Ltd.

INE317A01028
Amalgamation of Shasun Pharmaceuticals Ltd. into Strides Arcolab  Ltd
3
507446
Simbhaoli Sugars Ltd.
INE270C01017
Amalgamation of Simbhaoli Sugars Ltd. into Simbhaoli Spirits Ltd
4
500057
Aditya Birla Chemicals (India) Ltd.
INE605B01016
Amalgamation of Aditya Birla Chemicals (India) Limited into Grasim Industries Limited
5
532709
Reliance Natural Resources Ltd
INE328H01012

Transfer and vesting of the Business Undertaking of Reliance Natural Resources Ltd into Reliance Power Ltd.
6
632709
Reliance Natural Resources Ltd
INE328H01012

Transfer and vesting of the Business Undertaking of Reliance Natural Resources Ltd into Reliance Power Ltd.


 For any further clarification in respect of this notice, Trading Members may please contact the following persons: 


Sr. No.
Name of the Person
Tel. No.
1
Amol Hosalkar
22728390
2
Lakshmi Kadam
22728044



Marian D’souza 
Associate Manager –Listing Operations (CRD)
Contact No. 2272 8744
April 12, 2016

Tuesday, November 10, 2015

Shasun Pharma

Changes in S&P BSE Indices
 
Content
India, Mumbai, Tuesday Nov 10, 2015 - With reference to Notice no: 20151109-43, owing 
to amalgamation of Shasun Pharmaceuticals Ltd (Stock Code - 524552) with Strides
 Arcolab Ltd., Shasun Pharmaceuticals will be discontinued from trading effective 
November 18, 2015 which necessitates its exclusion from various indices.

Indices
Drop
Add
EFFECTIVE FROM

CODE
NAME
CODE
NAME
FFF

S&P BSE AllCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--
18-Nov-2015
S&P BSE 500
524552
Shasun Pharmaceuticals Ltd.
532659
IDFC Ltd.
0.84
S&P BSE Healthcare
524552
Shasun Pharmaceuticals Ltd.
--
--
--
S&P BSE MidSmallCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--
S&P BSE SmallCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--


For any information / clarification, you may contact Index Services on +91 22 2272 5261. You can also write us at index_services@spdji.com

ASIA INDEX PRIVATE LIMITED

Asia Index Pvt. Ltd is a 50-50 partnership between S&P Dow Jones Indices LLC, the world  s largest provider of financial market indices, and BSE Ltd, Asia  s oldest stock exchange and home to the iconic SENSEX index - a leading indicator of Indian equity market performance. Asia Index Pvt. Ltd, which combines the benchmarks, market intelligence, and insights of both parent companies, each established more than 115 years ago, aims to provide a full array of indices enabling global and domestic investors to participate in South Asia  s vibrant economies. The Company is best known for calculating, publishing, and maintaining a diverse family of Asian indices under the umbrella brand, S&P BSE Indices.